WO2001040521A3 - Nucleic acids containing single nucleotide polymorphisms and methods of use thereof - Google Patents

Nucleic acids containing single nucleotide polymorphisms and methods of use thereof Download PDF

Info

Publication number
WO2001040521A3
WO2001040521A3 PCT/US2000/032758 US0032758W WO0140521A3 WO 2001040521 A3 WO2001040521 A3 WO 2001040521A3 US 0032758 W US0032758 W US 0032758W WO 0140521 A3 WO0140521 A3 WO 0140521A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
methods
nucleotide polymorphisms
acids containing
containing single
Prior art date
Application number
PCT/US2000/032758
Other languages
French (fr)
Other versions
WO2001040521A2 (en
Inventor
Richard A Shimkets
Martin Leach
Original Assignee
Curagen Corp
Richard A Shimkets
Martin Leach
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curagen Corp, Richard A Shimkets, Martin Leach filed Critical Curagen Corp
Priority to CA002392948A priority Critical patent/CA2392948A1/en
Priority to AU19400/01A priority patent/AU1940001A/en
Priority to EP00982352A priority patent/EP1235936A2/en
Priority to JP2001542584A priority patent/JP2004508003A/en
Publication of WO2001040521A2 publication Critical patent/WO2001040521A2/en
Publication of WO2001040521A3 publication Critical patent/WO2001040521A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Abstract

The invention provides nucleic acids containing single-nucleotide polymorphisms identified for transcribed human sequences, as well as methods of using the nucleic acids.
PCT/US2000/032758 1999-11-30 2000-11-30 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof WO2001040521A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002392948A CA2392948A1 (en) 1999-11-30 2000-11-30 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
AU19400/01A AU1940001A (en) 1999-11-30 2000-11-30 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
EP00982352A EP1235936A2 (en) 1999-11-30 2000-11-30 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
JP2001542584A JP2004508003A (en) 1999-11-30 2000-11-30 Nucleic acids containing single nucleotide polymorphisms and methods of using the same

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16813899P 1999-11-30 1999-11-30
US60/168,138 1999-11-30
US72617300A 2000-11-29 2000-11-29
US09/726,173 2000-11-29

Publications (2)

Publication Number Publication Date
WO2001040521A2 WO2001040521A2 (en) 2001-06-07
WO2001040521A3 true WO2001040521A3 (en) 2002-05-16

Family

ID=26863832

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/032758 WO2001040521A2 (en) 1999-11-30 2000-11-30 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof

Country Status (5)

Country Link
EP (1) EP1235936A2 (en)
JP (1) JP2004508003A (en)
AU (1) AU1940001A (en)
CA (1) CA2392948A1 (en)
WO (1) WO2001040521A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7338937B2 (en) * 1997-11-17 2008-03-04 Cornell Research Foundation, Inc. Calcium-activated chloride channel proteins and their use in anti-metastatic therapy
AU2001281062A1 (en) * 2000-08-03 2002-02-18 Genaissance Pharmaceuticals, Inc. Haplotypes of the or1g1 gene
US7317077B2 (en) 2001-11-16 2008-01-08 Nymox Pharmaceutical Corporation Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
WO2004020662A2 (en) * 2002-08-27 2004-03-11 Epigenomics Ag Method and nucleic acids for the analysis of breast cell proliferative disorders
WO2005056838A1 (en) * 2003-12-08 2005-06-23 The Clinic For Special Children Association of tspyl polymorphisms with siddt syndrome
US7365058B2 (en) 2004-04-13 2008-04-29 The Rockefeller University MicroRNA and methods for inhibiting same
DE602006014519D1 (en) * 2005-12-16 2010-07-08 Nat Cancer Ct PEPTIDES FOR TRANSGLUTAMINASE INHIBITION
ATE514794T1 (en) 2006-05-12 2011-07-15 Gen Probe Inc COMPOSITIONS AND METHODS FOR THE DETECTION OF ENTEROCOCCAL NUCLEIC ACIDS

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0785280A2 (en) * 1995-11-29 1997-07-23 Affymetrix, Inc. (a California Corporation) Polymorphism detection
WO1998021316A1 (en) * 1996-11-15 1998-05-22 The New York Blood Center, Inc. Method of making monoclonal antibodies using polymorphic transgenic animals
WO1998030717A2 (en) * 1996-12-02 1998-07-16 Biocem S.A. Vegetal sequences including a polymorphic site and their uses
WO1998038846A2 (en) * 1997-03-07 1998-09-11 Affymetrix, Inc. Genetic compositions and methods

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0785280A2 (en) * 1995-11-29 1997-07-23 Affymetrix, Inc. (a California Corporation) Polymorphism detection
WO1998021316A1 (en) * 1996-11-15 1998-05-22 The New York Blood Center, Inc. Method of making monoclonal antibodies using polymorphic transgenic animals
WO1998030717A2 (en) * 1996-12-02 1998-07-16 Biocem S.A. Vegetal sequences including a polymorphic site and their uses
WO1998038846A2 (en) * 1997-03-07 1998-09-11 Affymetrix, Inc. Genetic compositions and methods

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL 11 September 1997 (1997-09-11), XP002173585 *
DATABASE EMBL 13 May 1998 (1998-05-13), XP002173584 *
WANG D G ET AL: "Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome", SCIENCE,US,AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, vol. 280, 1998, pages 1077 - 1082, XP002089398, ISSN: 0036-8075 *

Also Published As

Publication number Publication date
JP2004508003A (en) 2004-03-18
AU1940001A (en) 2001-06-12
EP1235936A2 (en) 2002-09-04
WO2001040521A2 (en) 2001-06-07
CA2392948A1 (en) 2001-06-07

Similar Documents

Publication Publication Date Title
WO2001047944A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
AU3719700A (en) Enzymatic dna molecules that contain modified nucleotides
WO2003097794A3 (en) Universal-tagged oligonucleotide primers and methods of use
AU2002365811A1 (en) Methods for the selection and cloning of nucleic acid molecules free of unwanted nucleotide sequence alterations
WO2000029623A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
AU6114700A (en) Novel system for the sequential, directional cloning of multiple dna sequences
AU2002314997A1 (en) Methods for low background cloning of dna using long oligonucleotides
AU2001285844A1 (en) Nucleotide sequences which code for the meth gene
AU2001259131A1 (en) Detection of nucleotide sequence variations via the proofreading activity of polymerases
WO2001048245A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2001040521A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
EP1551972A4 (en) Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
WO2000029622A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2001051670A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO1999046375A3 (en) Human nucleic acid sequences from prostate tissue
WO2001038586A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
AU2001293821A1 (en) Nucleotide sequences which code for the dead gene
AU2001293741A1 (en) Nucleotide sequences coding for the suga gene
AU2001278509A1 (en) Nucleotide sequences which code for the atr43 gene
WO2001047942A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
AU2002212232A1 (en) Nucleotide sequences which code for the dps gene
WO2003046143A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
AU2001293808A1 (en) Nucleotide sequences which code for the atr61 gene
AU2001291658A1 (en) Nucleotide sequences which code for the ccpa2 gene
AU2001289807A1 (en) Nucleotide sequences coding for the pstc2 gene

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2392948

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 19400/01

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2001 542584

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2000982352

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000982352

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000982352

Country of ref document: EP

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)